跳至主要内容
临床试验/NCT00565890
NCT00565890已完成不适用

Randomized Controlled Clinical Trial of Thyroxine Supplementation for Very-low-birth-weight Infants With Hypothyroxinemia During the First Month of Age

Tokyo Women's Medical University1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2005年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
100
试验地点
1
主要终点
Psychomotor development at 1.5 years of age

研究概览

简要总结

In order to determine the efficacy and safety of thyroxine replacement, a randomized clinical trial of thyroxine supplementation for VLBW infant with hypothyroxinemia during the first month of age is conducted.

详细描述

A prospective randomized unmasked controlled trial is conducted. Newborn infants with birth weight less than 1500g are randomized into thyroxine treatment or un-treatment group.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
2 Weeks 至 4 Weeks(Child)
性别
All
接受健康志愿者

入选标准

  • Birth weight: less than 1500g
  • Gestation: 22 weeks 0 day ≤
  • Serum free thyroxine level lower than 0.8 ng/dl
  • Serum thyrotropin lower than 10 μU/ml
  • Age of between 2 and 4 weeks after birth
  • Informed consent

排除标准

  • any known thyroid disease in mother

研究组 & 干预措施

2

No Intervention

No replacement therapy

干预措施: thyroxine (Drug)

结局指标

主要结局

Psychomotor development at 1.5 years of age

时间窗: 18 months

次要结局

  • Psychomotor development at 3 years of age(6 years)
  • Somatic growth at 3 years of age(6 years)
  • Duration of hospital stay(6 years)
  • Frequency of morbidities during the stay in NICu(6 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Satoshi Kusuda

Director

Tokyo Women's Medical University

研究点 (1)

Loading locations...

相似试验